BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9763574)

  • 1. Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.
    Saitoh K; Miura I; Takahashi N; Miura AB
    Blood; 1998 Oct; 92(8):2886-92. PubMed ID: 9763574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cytogenetics of stem cells: target cells of chromosome aberrations as revealed by the application of fluorescence in situ hybridization to fluorescence-activated cell sorting.
    Miura I; Takahashi N; Kobayashi Y; Saito K; Miura AB
    Int J Hematol; 2000 Oct; 72(3):310-7. PubMed ID: 11185986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Abnormal Clones in Myelodysplastic Syndrome Marrow Originate from Cells at a Pluripotent Stem Level and Maintain Their Early Differentiation Potency.
    Qi H; Qingxia Z; Xiao L; Lingyun W; Feng X; Zheng Z; Chunkang C
    Cancer Invest; 2015; 33(8):369-77. PubMed ID: 26135215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lineage involvement of stem cells bearing the philadelphia chromosome in chronic myeloid leukemia in the chronic phase as shown by a combination of fluorescence-activated cell sorting and fluorescence in situ hybridization.
    Takahashi N; Miura I; Saitoh K; Miura AB
    Blood; 1998 Dec; 92(12):4758-63. PubMed ID: 9845542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
    Bernell P; Jacobsson B; Nordgren A; Hast R
    Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting.
    Miura I; Kobayashi Y; Takahashi N; Saitoh K; Miura AB
    Br J Haematol; 2000 Sep; 110(4):876-9. PubMed ID: 11054073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.
    Kibbelaar RE; van Kamp H; Dreef EJ; de Groot-Swings G; Kluin-Nelemans JC; Beverstock GC; Fibbe WE; Kluin PM
    Blood; 1992 Apr; 79(7):1823-8. PubMed ID: 1558974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of clonality in myelodysplastic syndromes: detection of trisomy 8 in bone marrow cell smears by fluorescence in situ hybridization.
    Abruzzese E; Buss D; Rainer R; Rao PN; Pettenati MJ
    Leuk Res; 1996 Jul; 20(7):551-7. PubMed ID: 8795688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8.
    Nilsson L; Astrand-Grundström I; Anderson K; Arvidsson I; Hokland P; Bryder D; Kjeldsen L; Johansson B; Hellström-Lindberg E; Hast R; Jacobsen SE
    Blood; 2002 Jul; 100(1):259-67. PubMed ID: 12070035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8 studied by simultaneous immunophenotyping and fluorescence in situ hybridization.
    Nylund SJ; Verbeek W; Larramendy ML; Ruutu T; Heinonen K; Hallman H; Knuutila S
    Cancer Genet Cytogenet; 1993 Oct; 70(2):120-4. PubMed ID: 8242591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells.
    Murray LJ; Bruno E; Uchida N; Hoffman R; Nayar R; Yeo EL; Schuh AC; Sutherland DR
    Exp Hematol; 1999 Aug; 27(8):1282-94. PubMed ID: 10428505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma.
    Voso MT; Hohaus S; Moos M; Haas R
    Blood; 1997 May; 89(10):3763-8. PubMed ID: 9160682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation and differentiation of myelodysplastic CD34+ cells: phenotypic subpopulations of marrow CD34+ cells.
    Sawada K; Sato N; Notoya A; Tarumi T; Hirayama S; Takano H; Koizumi K; Yasukouchi T; Yamaguchi M; Koike T
    Blood; 1995 Jan; 85(1):194-202. PubMed ID: 7528567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of trisomy 12 and Rb-deletion in CD34+ cells of patients with B-cell chronic lymphocytic leukemia.
    Gahn B; Schäfer C; Neef J; Troff C; Feuring-Buske M; Hiddemann W; Wörmann B
    Blood; 1997 Jun; 89(12):4275-81. PubMed ID: 9192749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. A multiparameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studies.
    Fagioli F; Cuneo A; Bardi A; Carli MG; Bigoni R; Balsamo R; Previati R; Pazzi I; Roberti G; Rigolin GM
    Cancer Genet Cytogenet; 1995 Jul; 82(2):116-22. PubMed ID: 7664240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117.
    Haase D; Feuring-Buske M; Schäfer C; Schoch C; Troff C; Gahn B; Hiddemann W; Wörmann B
    Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous occurrence of myelodysplastic syndrome and monoclonal B lymphocytes with a different clonal origin.
    Cauwelier B; Nollet F; De Laere E; Van Leeuwen M; Billiet J; Criel A; Louwagie A
    Leuk Lymphoma; 2002 Jan; 43(1):191-3. PubMed ID: 11908728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes.
    Soenen V; Fenaux P; Flactif M; Lepelley P; Lai JL; Cosson A; Preudhomme C
    Br J Haematol; 1995 Jul; 90(3):701-6. PubMed ID: 7647013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Programmed cell death is an intrinsic feature of MDS progenitors, predominantly found in the cluster-forming cells.
    Span LF; Vierwinden G; Pennings AH; Boezeman JB; Raymakers RA; de Witte T
    Exp Hematol; 2005 Apr; 33(4):435-42. PubMed ID: 15781334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.